Kryssia I Rodriguez-Castro
Overview
Explore the profile of Kryssia I Rodriguez-Castro including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
222
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rodriguez-Castro K, Vitale A, Fadin M, Shalaby S, Zerbinati P, Sartori M, et al.
Eur J Gastroenterol Hepatol
. 2018 Sep;
31(1):34-42.
PMID: 30188408
Background And Objective: Portal vein thrombosis (PVT) is a common complication in cirrhosis, and when complete, it increases morbidity and mortality in liver transplant candidates. The aim of the study...
2.
Burra P, Rodriguez-Castro K
World J Gastroenterol
. 2015 Aug;
21(29):8753-68.
PMID: 26269665
De novo neoplasms account for almost 30% of deaths 10 years after liver transplantation and are the most common cause of mortality in patients surviving at least 1 year after...
3.
Burra P, Rodriguez-Castro K, Rigotti P
Transpl Int
. 2014 Dec;
28(5):620-1.
PMID: 25488696
No abstract available.
4.
Cholongitas E, Mamou C, Rodriguez-Castro K, Burra P
Transpl Int
. 2014 Jun;
27(10):1039-49.
PMID: 24943720
Calcineurin inhibitors (CNIs) have been associated in a dose-dependent fashion with an increased risk of post-transplant hepatocellular carcinoma (HCC) recurrence. The mammalian target of rapamycin inhibitors (mTORi) (sirolimus/everolimus) might represent...
5.
Burra P, Rodriguez-Castro K, Marchini F, Bonfante L, Furian L, Ferrarese A, et al.
Transpl Int
. 2014 May;
27(9):877-91.
PMID: 24853721
Liver disease secondary to chronic hepatitis C virus (HCV) infection is an important cause of morbidity and mortality in patients with end-stage renal disease (ESRD) on renal replacement therapy and...
6.
Rodriguez-Castro K, DAmico F, Polacco M, Bertacco A, Burra P, Senzolo M, et al.
Transplantation
. 2013 Nov;
96(10):e69-71.
PMID: 24247902
No abstract available.
7.
Rossetto V, Spiezia L, Senzolo M, Rodriguez-Castro K, Maggiolo S, Simioni P
Thromb Res
. 2013 Jul;
132(2):e131-4.
PMID: 23810655
The coagulation pattern and the determinants of portal vein thrombosis (PVT), both in patients with and without cirrhosis, are still largely unknown. The aim of this study was to evaluate...
8.
Rodriguez-Castro K, Porte R, Nadal E, Germani G, Burra P, Senzolo M
Transplantation
. 2012 Nov;
94(11):1145-53.
PMID: 23128996
Background: Nonneoplastic portal vein thrombosis (PVT) is frequent in patients with cirrhosis who undergo liver transplantation (LT); however, data on its impact on outcome and strategies of management are sparse....
9.
Rodriguez-Castro K, Simioni P, Burra P, Senzolo M
Liver Int
. 2012 Jun;
32(10):1465-76.
PMID: 22734713
Cirrhotic patients can develop thrombotic complications, which in this group of patients occur with a greater frequency than in the general population. Portal vein thrombosis (PVT) is the most common...